NOVEN PHARMACEUTICALS Revenue, Growth & Competitor Profile

Company Profile & Annual Report for Noven Pharmaceuticals

Access the complete profile.

Noven Pharmaceuticals Fast Facts

Revenue	$100 - $500 million    See Exact Annual Revenue
Employees	100 - 500Exact Company Size
Primary Industry	325411 Medicinal & Botanical Manufacturing
Additional NAICS Codes	32541 62151
Address	11960 S.w. 144th Street Miami, FL 33186 noven.com

Note: Revenues for privately held companies are statistical evaluations.




Noven Pharmaceuticals's Annual Report & Profile shows critical firmographic facts:

• What is the company's size? (Annual sales and employees)
• What industry is the company in?

Noven Pharmaceuticals Annual Revenue and Growth Rate

Noven Pharmaceuticals	Revenue Est. ($ Million)	Growth Rate (%)	# Employees
2023	Details in Premium Report
2022
2021
2020
2019

1-Year Growth Rate: 3-Year Growth Rate (CAGR):

Note: Noven Pharmaceuticals's revenues are gauged from an analysis of company filings.

Noven Pharmaceuticals's Income Statement (based on Industry Averages)

	$ Millions (Industry Average)
Noven Pharmaceuticals Revenue (Sales)
Cost of Goods Sold
Gross Profit
Operating Expenses
Advertising
Salaries and wages
Other Operating Expenses
Total Operating Expenses
Operating Income
EBITDA
EBIT (Earnings Before Interest and Taxes)
Net Profit

Trademark Applications

Trademark applications show the products and services that Noven Pharmaceuticals is developing and marketing. Noven Pharmaceuticals doesn't have any recent trademark applications, indicating Noven Pharmaceuticals is focusing on its existing business rather than expanding into new products and markets. Trademarks may include brand names, product names, logos and slogans.

Trademark	Date
WENLY Pharmaceutical preparations, namely, contraceptives in the form of a transdermal patch	05/06/2021
APHNEVE Pharmaceutical preparations, namely, contraceptives in the form of a transdermal patch	05/06/2021
BITZEE Pharmaceutical preparations, namely, contraceptives in the form of a transdermal patch	05/03/2021

See all trademarks and details in the Full Report.

Recession Risk

Determine whether Noven Pharmaceuticals grew or shrank during the last recession. This is useful in estimating the financial strength and credit risk of the company. Compare how recession-proof Noven Pharmaceuticals is relative to the industry overall. While a new recession may strike a particular industry, measuring the industry and company's robustness during the last recession estimates its ability to weather future recessions.

Market Share of Noven Pharmaceuticals's Largest Competitors

A competitive analysis shows these companies are in the same general field as Noven Pharmaceuticals, even though they may not compete head-to-head. These are the largest companies by revenue. However, they may not have the largest market share in this industry if they have diversified into other business lines. The "Competition" section of a business plan or investment memorandum would start by analyzing the information about these companies. Competitive advantage comes from offering better pricing or superior products/service.

Company	Headquarters	Revenue ($ MM)
XYMOGEN	Orlando, FL	100
AVANTI NUTRITIONAL LABORATORIES	Miami Lakes, FL	37
NUTRITION FORMULATORS	Miramar, FL	36
RTPR	Cabot, AR	33
INTEGRATED BOTANICS	Fort Worth, TX	29
COSMAX NBT USA	Garland, TX	29
CJB INDUSTRIES	Valdosta, GA	28
ALTERNATIVE LABORATORIES	Naples, FL	28
S&B PHARMA	Azusa, CA	28

Nearby Competitors

These companies are similar in business line and location to Noven Pharmaceuticals. While some companies compete with neighboring businesses for customers, other companies may compete to attract skilled employees.

Company	Headquarters	Revenue ($ MM)
CANSORTIUM HOLDINGS	Miami, FL	100
SOFGEN PHARMACEUTICALS	Aventura, FL	26
NOVEN PHARMACEUTICALS	Miami, FL	21
INNOVA SOFTGEL	Miami, FL	16
03 USA	Miami, FL	14
ORGANABIO	South Miami, FL	6

Future Competition: Noven Pharmaceuticals's Fastest Growing Competitors

These companies are in the same general field as Noven Pharmaceuticals and are rapidly expanding. Companies may grow organically or through acquisition. In some cases apparently high growth rates may be caused by data that weren't available in previous years.

Company	Revenue ($ MM)